Does Argireline help with comparison with botulinum toxin? Grade D evidence

What the studies show

No trial has compared argireline with botulinum toxin injections. The marketing comparison rests on a shared molecular target in vitro, not on any head-to-head result.

Animal studies, cell studies, or anecdotes only. This is where almost every viral peptide sits. Promising and proven are different words for a reason.

In context

Argireline is a synthetic hexapeptide (acetyl hexapeptide-8) modelled on the end of SNAP-25, the protein botulinum toxin cuts, and sold in serums as a topical wrinkle treatment. Its human evidence is one 60-person randomised trial over four weeks, which reported reduced periorbital roughness and a 48.9% subjective anti-wrinkle rate against 0% on placebo. The same study appears three times in the 2013 literature under different titles. It is a legal cosmetic ingredient everywhere LYO covers and is not a medicine.

Argireline is cosmetic ingredient. Legal status differs by country — see the regulation section or the jurisdiction pages.

Questions

Is Argireline proven to help with comparison with botulinum toxin?

No. There is no human evidence for it (None); the claim rests on animal or cell studies and LYO grades it D.

What studies are behind the grade?

No trial has compared argireline with botulinum toxin injections. The marketing comparison rests on a shared molecular target in vitro, not on any head-to-head result.

Is Argireline approved for this?

No. Argireline is cosmetic ingredient; it is not an approved medicine for any indication in the jurisdictions LYO covers.

Other outcomes for Argireline

CPeriorbital wrinkles and skin roughness (topical)1 RCT (n=60, 4 wk)
CSubjective wrinkle improvement (topical)1 RCT (n=60, 4 wk)
CSafety (topical)adverse1 RCT (n=60)

Written and maintained by LYO Research — how pages are written and checked. Reviewed 29 October 2026. Grades count human evidence only; see how LYO grades. Not medical advice. Correct this page →